Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker TNYA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 7,406 | $0.71 | $5,258 Sale | Form 4 ↗ |
| Aug 17, 2026 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 5,020 | $0.71 | $3,564 Sale | Form 4 ↗ |
| Aug 17, 2026 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 3,969 | $0.71 | $2,818 Sale | Form 4 ↗ |
| Aug 17, 2026 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 5,837 | $0.71 | $4,144 Sale | Form 4 ↗ |
| Aug 17, 2026 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 2,279 | $0.71 | $1,618 Sale | Form 4 ↗ |
| Aug 17, 2026 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,871 | $0.71 | $1,328 Sale | Form 4 ↗ |
| Aug 17, 2026 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,637 | $0.71 | $1,162 Sale | Form 4 ↗ |
| Aug 17, 2026 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,637 | $0.71 | $1,162 Sale | Form 4 ↗ |
| May 18, 2026 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 3,390 | $0.79 | $2,678 Sale | Form 4 ↗ |
| May 18, 2026 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 3,121 | $0.79 | $2,466 Sale | Form 4 ↗ |
| May 18, 2026 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 1,485 | $0.79 | $1,173 Sale | Form 4 ↗ |
| Feb 25, 2026 | TCG Opportunity III GP, LLC 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 1.86M | $0.56 | $1.0M Sale | Form 4 ↗ |
| Feb 25, 2026 | TCG Opportunity III GP, LLC 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 1.65M | $0.56 | $923.6K Sale | Form 4 ↗ |
| Feb 24, 2026 | TCG Opportunity III GP, LLC 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 349,212 | $0.62 | $216.5K Sale | Form 4 ↗ |
| Feb 24, 2026 | TCG Opportunity III GP, LLC 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 309,228 | $0.62 | $191.7K Sale | Form 4 ↗ |
| Feb 23, 2026 | Column Group III-A, LP 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 162,291 | $0.60 | $97.4K Sale | Form 4 ↗ |
| Feb 23, 2026 | Column Group III-A, LP 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 143,709 | $0.60 | $86.2K Sale | Form 4 ↗ |
| Feb 20, 2026 | Column Group III-A, LP 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 277,769 | $0.61 | $169.4K Sale | Form 4 ↗ |
| Feb 20, 2026 | Column Group III-A, LP 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 245,965 | $0.61 | $150.0K Sale | Form 4 ↗ |
| Feb 17, 2026 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 2,022 | $0.64 | $1,294 Sale | Form 4 ↗ |
| Feb 17, 2026 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 836 | $0.64 | $535 Sale | Form 4 ↗ |
| Feb 17, 2026 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 611 | $0.64 | $391 Sale | Form 4 ↗ |
| Feb 17, 2026 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 5,032 | $0.64 | $3,220 Sale | Form 4 ↗ |
| Feb 17, 2026 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 3,979 | $0.64 | $2,547 Sale | Form 4 ↗ |
| Feb 17, 2026 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 5,851 | $0.64 | $3,745 Sale | Form 4 ↗ |
| Feb 17, 2026 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,876 | $0.64 | $1,201 Sale | Form 4 ↗ |
| Feb 17, 2026 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,642 | $0.64 | $1,051 Sale | Form 4 ↗ |
| Feb 17, 2026 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,642 | $0.64 | $1,051 Sale | Form 4 ↗ |
| Feb 11, 2026 | Column Group III-A, LP 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 2.15M | $0.68 | $1.5M Sale | Form 4 ↗ |
| Feb 11, 2026 | Column Group III-A, LP 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 1.91M | $0.68 | $1.3M Sale | Form 4 ↗ |
| Feb 10, 2026 | Column Group III-A, LP 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 182,295 | $0.82 | $149.5K Sale | Form 4 ↗ |
| Feb 10, 2026 | Column Group III-A, LP 10% owner | TNYA Tenaya Therapeutics, Inc. | Sale | 161,422 | $0.82 | $132.4K Sale | Form 4 ↗ |
| Nov 17, 2025 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 1,367 | $1.33 | $1,818 Sale | Form 4 ↗ |
| Nov 17, 2025 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 2,877 | $1.33 | $3,826 Sale | Form 4 ↗ |
| Nov 17, 2025 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 3,126 | $1.33 | $4,158 Sale | Form 4 ↗ |
| Aug 18, 2025 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,837 | $1.25 | $2,296 Sale | Form 4 ↗ |
| Aug 18, 2025 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,608 | $1.25 | $2,010 Sale | Form 4 ↗ |
| Aug 18, 2025 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 1,608 | $1.25 | $2,010 Sale | Form 4 ↗ |
| Aug 18, 2025 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 4,920 | $1.25 | $6,150 Sale | Form 4 ↗ |
| Aug 18, 2025 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 3,893 | $1.25 | $4,866 Sale | Form 4 ↗ |
| Aug 18, 2025 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 5,720 | $1.25 | $7,150 Sale | Form 4 ↗ |
| Aug 18, 2025 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 1,722 | $1.25 | $2,153 Sale | Form 4 ↗ |
| Aug 18, 2025 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 717 | $1.25 | $896 Sale | Form 4 ↗ |
| Aug 18, 2025 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 523 | $1.25 | $654 Sale | Form 4 ↗ |
| May 16, 2025 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 1,390 | $0.44 | $612 Sale | Form 4 ↗ |
| May 16, 2025 | Whittemore Tingley Chief Medical Officer | TNYA Tenaya Therapeutics, Inc. | Sale | 2,937 | $0.44 | $1,292 Sale | Form 4 ↗ |
| May 16, 2025 | Ali Faraz Chief Executive Officer, Director | TNYA Tenaya Therapeutics, Inc. | Sale | 3,189 | $0.44 | $1,403 Sale | Form 4 ↗ |
| Mar 10, 2025 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 845 | $0.54 | $456 Sale | Form 4 ↗ |
| Mar 10, 2025 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 620 | $0.54 | $335 Sale | Form 4 ↗ |
| Mar 10, 2025 | Tomohiro Higa SVP, Finance | TNYA Tenaya Therapeutics, Inc. | Sale | 1,017 | $0.54 | $549 Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances